|
Quotes & Info
|
| GNBT > SEC Filings for GNBT > Form 8-K on 30-Jan-2013 | All Recent SEC Filings |
30-Jan-2013
Regulation FD Disclosure, Financial Statements and Exhibits
On January 29, 2013, Generex Biotechnology Corporation (the "Company") announced the details for accessing a conference call, scheduled for Thursday, January 31, 2013 at 10:00 a.m. Eastern Standard Time, to update the investment community on the Company's flagship product, Generex Oral-lyn™ and other corporate activities. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
(d) Exhibits.
Exhibit
Number Description
99.1 Press release issued by Generex Biotechnology Corporation dated
January 29, 2013
|
|
|